Article Text
Statistics from Altmetric.com
I write in response to the article published in your journal “Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia” (Bruno C et al, BMJ Qual Saf 2019). I am writing as NPS MedicineWise evaluation found a significant impact on general practitioner (GP) prescribing of proton pump inhibitors (PPIs) following their educational programmes in 2009 and 2015. I acknowledge that the article is well written, the methods are well described and the approach includes a number of sensitivity analyses. However, I would like to highlight some key points on the analysis methods used that differ from the approach taken by NPS MedicineWise and about which I have some concerns.
The 2015 NPS MedicineWise educational programme on PPIs was part of a larger educational strategy over a decade to support best-practice prescribing of PPIs by GPs and included Pharmaceutical Benefits Scheme (PBS) feedback to GPs in Australia. This consists of a letter that includes information of the individual GP’s prescribing of PPIs compared with …
Footnotes
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; internally peer reviewed.